Skip to main content
Premium Trial:

Request an Annual Quote

BioServe to Provide Genetic Testing for NGC Medical

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioServe said today that it will provide its genetic testing services for NGC Medical's nutrigenomics testing business.

Under the agreement, BioServe will provide Italy's NGC Medical with its CLIA-certified genomics services, including DNA extraction, QC DNA, and control DNA for the NutriGeneCode testing service.

Beltsville, Md.-based BioServe said that it expects to process around 10,000 NutriGeneCode tests in the next year.

The NutriGeneCode test uses a saliva sample to identify 50 SNPs that are involved in cellular aging and body response, such as lipid and carbohydrate metabolism, hypertension, inflammation, oxidation, and detoxification reactions and DNA repair.

Financial terms of the agreement were not released, but BioServe said that negotiations are ongoing to "develop a more comprehensive partnership between the two companies."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.